IEQ Capital’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$379K Buy
272,855
+97,473
+56% +$188K ﹤0.01% 1501
2026
Q2
$363K Buy
175,382
+83,149
+90% +$149K ﹤0.01% 1553
2026
Q1
$185K Hold
92,233
– – ﹤0.01% 1713
2025
Q4
$104K Hold
92,233
– – ﹤0.01% 1758
2025
Q3
$169K Buy
+92,233
New +$79.9K ﹤0.01% 1704

Other funds holding ALXO

IEQ Capital's ALXO Position: Q3 2026 in Review

IEQ Capital increased its ALX Oncology (ALXO) stake by 56% in Q3 2026, buying an estimated $188K and bringing the position to 272,855 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

IEQ Capital first reported a position in ALXO in Q3 2025 and has held it in 5 quarters since. 112 funds tracked by Wall St. Rank hold ALXO as of Q3 2026.

  • IEQ Capital held 272,855 shares of ALX Oncology worth $379K as of Q3 2026.
  • IEQ Capital bought 97,473 ALX Oncology shares in Q3 2026, an estimated $188K.
  • ALX Oncology made up ﹤0.01% of IEQ Capital's portfolio in Q3 2026, its #1501 holding.
  • IEQ Capital first reported a position in ALX Oncology in Q3 2025 and has held it in 5 quarters since.
  • 112 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.